DavidCFaragherMD

Rocky Mountain Cancer Centers

Dr. Faragher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1986 - 1989
Fitzsimons Army Medical CenterResidency, Internal Medicine, 1983 - 1986
University of South Dakota, Sanford School of MedicineClass of 1983

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

PubMed

5 citations
An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphoma
Nicholas J. Di Bella, Craig W. Reynolds, David C. Faragher, Joseph Muscato, Kristi A. Boehm, Lina Asmar> ;Cancer. 2005 Mar 1
10 citations
Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen
Robert Drapkin, Nicholas J. Di Bella, David C. Faragher, Elizabeth Harden, Carmen Matei, William J. Hyman, Mae Y. Mirabel, Kristi A. Boehm, Lina Asmar> ;Clinical Lymphoma. 2003 Dec 1
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia ...
Cooper, M. R., Dear, K., McIntyre, O. R., Ozer, H., Ellerton, J., Canellos, G., Bernhardt, B., Duggan, D., Faragher, D., Schiffer, C.> ;J Clin Oncol. 1993 Jan
Bilateral synchronous testicular germ cell cancer.
Redmond, J., Samaha, M. A., Charles, R. S., Vukelja, S. J., Faragher, D., Tenglin, R., Reid, T., Dawson, N., Auerbach, H., Richter, M. P.> ;South Med J. 1995 Mar
Join now to see all